Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials
Authors:
- Daniel J SchnellDSDaniel J Schnell
- Richard L PageRPRichard L Page
- William E WilkinsonWWWilliam E Wilkinson
- Stephen R MarcelloSMStephen R Marcello
- Edward L.C PritchettEPEdward L.C Pritchett
- 1 September 2003
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 146 (3) , 489-493
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Antiarrhythmic effects of azimilide in paroxysmal supraventricular tachycardia: Efficacy and dose-responseAmerican Heart Journal, 2002
- Effects of Azimilide on Heart Rate and ECG Conduction Intervals during Sinus Rhythm in Patients with a History of Atrial FibrillationThe Journal of Clinical Pharmacology, 2002
- Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillationThe American Journal of Cardiology, 2001
- Antiarrhythmic effects of azimilide in atrial fibrillation: efficacy and dose-responseJACC, 2000
- Pharmacology of Azimilide Dihydrochloride (NE‐10064), A Class III Antiarrhythmic AgentCardiovascular Drug Reviews, 1997